Jafron blood filter during heart surgery in children
Part of Heart & circulation, Immune system & allergy clinical trials.
This study tests a special filter (Jafron) used during open-heart surgery in children. The filter is placed in the heart-lung machine to remove substances that may cause inflammation and help recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 10 years old or younger.
- Your child must weigh at least 5 kg (about 11 pounds).
- Your child is scheduled for open-heart surgery that will use a heart-lung machine for at least 2 hours.
- The parent or legal guardian must agree to the study and sign a consent form.
- Your child must not have a known allergy to heparin, which is a blood thinner used during surgery.
- Your child must not have a platelet count below 20 (measure of a type of blood cell) before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special filter (HA380 column) used during dialysis or ECMO to remove harmful substances from the blood. It is for critically ill patients with severe infection, injury, or breathing problems who also need kidney or lung support.
This study tests whether using a special blood filter during heart surgery can reduce harmful inflammation. It may help children recover better after long surgeries.
This trial compares two ways to filter blood during heart surgery in young children to see which method works better. It may help kids under 5 who need heart surgery with a heart-lung machine.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests a special blood-filtering device (Efferon LPS) used during heart surgery to reduce inflammation and improve recovery. The device removes harmful substances from your blood during the operation.
This trial tests a blood-filtering device (Efferon LPS NEO) that removes harmful substances from the blood of children with severe thermal burns. It may help reduce complications and improve recovery.
Hear when a new Cardiac Surgery Recovery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.